CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
Gibraltar, British Overseas Territories, January 16th, 2025, ChainwireAurora Labs has announced the launch of the Aurora ...
BreakPoint Labs, LLC ("BreakPoint Labs"), a technically proficient, mission-focused cybersecurity service provider, is ...
A new benchmark in blockchain innovation is being set with advanced smart contract services. Offering expert auditing and ...